Medi Assist Healthcare IPO GMP Today and Expected Listing Price
The Indian healthcare sector has been a buzz with the upcoming initial public offering (IPO) of Medi Assist Healthcare, all set to open its doors for subscription on January 15th, 2024. Medi Assist has not only piqued investor interest but also sparked widespread curiosity about its prospects. So, if you’re wondering about the potential Grey Market Premium (GMP) and expected listing price for this healthcare giant’s IPO, buckle up, grab your stethoscopes, and let’s dive into a comprehensive analysis!
Understanding the Medi Assist Play:
Before dissecting the numbers, let’s gain some ground on the company itself. Established in 2002, Medi Assist has carved a niche as a leading TPA, managing health benefits for employers, retail members, and even public health schemes. Think of the company as the behind-the-scenes orchestrators, processing claims, verifying bills, and ensuring smooth sailing for both insurers and policyholders.
Their consistent success over the years truly speaks for itself. Medi Assist boasts a robust network of over 85,000 healthcare providers, catering to 36.40 million lives – that’s roughly the population of New Zealand! With a robust presence across 25 states and union territories, their reach and expertise solidify their position as a key player in the ever-evolving healthcare landscape.
The IPO Decoded:
Now, onto the nitty-gritty – the IPO itself. This is an entirely Offer-for-Sale (OFS) affair, meaning no fresh capital is being raised. Existing shareholders, including promoters and investors like Bessemer Health Capital and Investcorp, are looking to offload part of their stakes. Here’s a quick snapshot of the key details:
- Issue Size: Up to 2.8 crore equity shares
- Price Band: ₹397 to ₹418 per share
- Issue Dates: Subscription opens on January 15th, closes on January 17th
- Listing Dates: Tentatively set for January 22nd on BSE and NSE
Key Financial Numbers:
| Period Ended | Assets | Revenue | Profit After Tax | Net Worth | Reserves and Surplus |
|---|---|---|---|---|---|
| 30 Sep 2023 | 802.62 | 312.03 | 22.49 | 416.64 | 102.03 |
| 31 Mar 2023 | 705.72 | 318.96 | 74.04 | 383.67 | 353.86 |
| 31 Mar 2022 | 602.23 | 412.02 | 64.22 | 339.29 | 308.63 |
| 31 Mar 2021 | 545.30 | 345.57 | 26.27 | 292.55 | 295.81 |
Medi Assist Healthcare IPO GMP Today:
The Medi Assist Healthcare IPO GMP Today, is whispering promising scope for Medi Assist. The GMP, an indicator of investor sentiments before the official listing, has been around ₹82 per share, translating to a potential premium of 20% at the upper end of the price band.
Generally, past performance isn’t a crystal ball, but it can give us clues about the future. Just look at Max Healthcare and Gland Pharma, they went public recently and people jumped all over their shares, pushing the price with a good margin. This excitement seems to be replacting on Medi Assist also, making everyone think it might have a smooth start when it will hit the stock market.
Predicting the Listing Price:
Analysing the Grey Market premium and predicting the actual listing price is not an exact science. However, by piecing together market sentiment, company’s fundamentals, and other factors, we can try to paint a somewhat estimated picture of the listing price. The healthy GMP, strong leadership, and the booming healthcare sector point towards a potentially positive listing of ₹500 approximately.
Market analysts are also cautiously optimistic, expecting the listing price to go more upward within the upper half of the price band, depending on investor demand for the IPO during the subscription period.
Should You Invest?
As always, caution and due diligence is paramount before investing. While the prospect of Medi Assist healthcare’s IPO might be tempting, remember that every investment carries its own set of risks. Also, as per our analysis this IPO will give you positive results.
Disclaimer: Also, do your due diligence, thoroughly research the company’s financials, consider your risk appetite, and seek professional advice if required. Remember, Medi Assist’s success will depend on many factors like regulatory changes, competition, overall economic health and many more.
Read our other blogs from below links: